IL17A and type 1 diabetes mellitus: Quantitative and qualitative alterations in circulating Tregs have been documented in autoimmune diseases such as type 1 diabetes (T1D), characterized by reduced suppressive function, decreased stability of FoxP3 expression, and increased secretion of proinflammatory cytokines (IFN-γ, IL-17) (3, 4).